Peptide Synthesis Market Size & Share, by Product (Equipment, Reagents & Consumables); Technology (Solid Phase, Liquid Phase, Hybrid & Recombinant); End-user {Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO), Research Institutes} - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4800
  • Published Date: Apr 08, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Peptide Synthesis Market size is expected to cross USD 6 billion by the end of 2035, growing at a CAGR of 10% during the forecast period i.e., 2023-2035. In the year 2022, the industry size of peptide synthesis was USD 2 billion. The market growth can be attributed to the escalating integration of precision medicines and the high demand for personalized medicine. The development of personalized medicines enables doctors to tailor treatments to each individual patient’s oriented needs and characteristics. Thus, with increasing investment in the R&D of precise medicines the demand for peptide synthesis is expected to increase in the future.

Besides, there are more factors behind the expansion of the peptide synthesis market such as rising emphasis on protein-based therapeutics such as recombinant proteins, and the high prevalence of cardiovascular diseases, reported by the World Health Organization every year around 17.9 million deaths take place globally due to cardiovascular diseases.


Peptide Synthesis Market
Get more information on this report: Request Free Sample PDF

Peptide Synthesis Sector: Growth Driver and Challenges

Growth Drivers

  • Escalating Usage of Peptides in Pharmaceutical Drugs Along with A Rise in FDA Approval- Peptides offer fewer side effects and can be absorbed quickly into the body.  Moreover, they are more cost-friendly to produce and are much more stable as compared to traditional drug substances, as a result making them the better choice for several pharmaceutical drugs. Additionally, the FDA has approved eight peptides, two oligonucleotides, and two ADCs that consist of peptides out of fifty drugs that were submitted to the FDA in 2021.
  • Surge in Usage of Peptides for Curing COVID-19 – As per the research published in August 2022, over 100 peptides were under development for the COVID-19 diagnostics and treatment virus. In this 15 were synthetic peptides for acute respiratory distress syndrome and several other respiratory sicknesses caused by SAES-Cov-2. Basically, peptides are originally obtained from the human body and have the ability to develop into effective therapies due to their potential to focus specific receptors in the body.
  • Growing Expenditure by Pharmaceutical Industry on R&D along with Growth in Drug Approvals – Such as, in the United States in 2019 over USD 83 million was spent on research and development by the pharmaceutical sector. Also, the number of new drug-approved sales grew by 60% between 2010 to 2019, which rose compared to the previous decade.
  • High Prevalence of Cancer Globally – Reported in 2020 as per American Cancer Society Journal, men had a 19% higher incidence rate of cancer as compared to women. Peptides have been used in multiple cancer cases and have shown relevant results in treatment. Moreover, the high demand for better treatment and therapies for cancer is predicted to boost the market growth in the projected period.
  • Development and Approval of Advanced Peptides for Obesity and Weight Gain – As per the US FDA, Imcivree, a pro-opiomelanocortin-derived peptide, was approved for chronic weight management for obese patients with unique genetic circumstances aged six years or above.

Challenges

  • Tough Regulatory Framework and Strict Approval Procedure for Peptide-based Products – The difficulty in the regulatory framework and approval procedure makes it tough for companies to bring the latest peptide-based products to market, as the procedure is both time-consuming and high in cost. This creates limitations to the entry of new companies and hamper market expansion in the upcoming future.
  • Expensive Raw Materials
  • Lack of Knowledge in Peptide Synthesis

Peptide Synthesis Market: Key Insights

Base Year

2022

Forecast Year

2023 – 2035

CAGR

10%

Base Year Market Size (2022)

USD 2 billion

Forecast Year Market Size (2035)

USD 6 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Peptide Synthesis Segmentation

Product (Equipment, Reagents & Consumables)

The reagent & consumable segment is expected to dominate the global peptide synthesis market registering a CAGR of 53% by the end of 2035. This section includes both inorganic and organic substances that are employed in the production of various peptide types. The market is expanding as a result of the growing need for peptides in medication discovery and research. For instance, research on peptide hormones resulted in 6020 items in the HORDB database, comprising 5720 peptide hormones and 42 peptide medicines.

End User {Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO), Research Institutes}

Peptide synthesis market from the pharmaceutical and biotechnology company segment is estimated to witness the highest CAGR of 35% in the estimated period. The segment's expansion may be ascribed to the brisk expansion of biotechnology and pharmaceutical firms, the rise in biologic drug production, and expanding public knowledge of peptide synthesis technology. The Indian pharmaceutical sector is set to reach USD 130 billion by the end of 2030. Peptide synthesis technology is in higher demand due to the growth in the amount of pharma and biotechnology firms, which has resulted in the creation of more sophisticated peptide synthesis products.

Our in-depth analysis of the global Peptide synthesis market includes the following segments:

 

     Product

  • Equipment
  • Reagents & Consumables

 

 

     Technology

  • Solid Phase
  • Liquid Phase
  • Hybrid & Recombinant

 

 

 

     End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Development and Manufacturing Organization (CDMO)
  • Research Institutes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Peptide Synthesis Industry - Regional Synopsis

North America Market Statistics

The peptide synthesis sector in the North America region is set to witness the largest market share, registering a CAGR of 35% by the end of the forecast period. The government and academic institutions' increasing efforts to create innovative peptide-based medicinal pharmaceuticals can be largely responsible for the market's expansion in the region. The market for peptide synthesis in North America is expanding due to the rising incidence of chronic diseases including diabetes, and cancer, as well as the rising need for peptide-based medications. For instance, according to a recent assessment by the International Diabetic Federation (IDF), 14.096 percent of persons in the North America and Caribbean (NAC) area aged 20 and older were predicted to have diabetes in 2021.

APAC Market Forecast

In the Asia Pacific region, the peptide synthesis market is anticipated to grow significantly during the time period between 2023 – 2035. Market growth is mainly influenced due to technological advancements in peptide synthesis. The aging population in this region is expected to drive the growth of the regional peptide market. As people age, their bodies become more susceptible to chronic diseases that require special treatment. In addition, the rise of the biotechnology and biopharmaceutical sector is also expected to drive the regional growth of the market during the studied period. 

Research Nester
Peptide Synthesis Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Peptide Synthesis Landscape

top-features-companies
    • CordenPharma International
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Evonik
    • CSBio Company Inc.
    • Bachem Holding AG
    • Biotage
    • AAPP Tec
    • CEM Corporation
    • ProteoGenix
    • GenScript
    • Thermo Fisher Scientific Inc.

In the News

  • Evonik has released a new peptide to boost cell-culture-based biopharmaceutical productivity. cWrex AC provides cells with a sufficient supply of soluble sources of this amino acid. The peptide offers a reliable source of L-cystine, which is an essential component for cell-culture-based biopharmaceuticals. This makes it possible for biopharmaceutical companies to increase their productivity by providing cells with a consistent and sufficient supply of amino acids.
     
  • CordenPharma International Company announced a collaboration with PeptiSystems, a Swedish manufacturer of flow-through column-based instruments for the research and production of peptide and oligonucleotide therapeutics.

Author Credits:  Smruti Ranjan, Rajrani Baghel


  • Report ID: 4800
  • Published Date: Apr 08, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing expenditure by the pharmaceutical industry on R&D along with growth in drug approvals and high usage in COVID-19 treatment are some of the major factors anticipated to drive the growth of the polymer concrete market.

The market is anticipated to attain a CAGR of 10% over the forecast period, i.e., 2023-2035.

The major players in the market are Bachem Holding AG, Biotage, AAPP Tec, CEM Corporation, and others.

The pharmaceutical & biotechnology companies segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Peptide Synthesis Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying